Prof. Dr. rer. nat. Helge Taubert



Organisationseinheit


Urologische Klinik
Professur für Molekulare Urologie


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 7 Go to next page Go to last page

Eckstein, M., Sailer, V., Nielsen, B.S., Wittenberg, T., Wiesmann, V., Lieb, V.,... Wach, S. (2019). Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays. Laboratory Investigation. https://dx.doi.org/10.1038/s41374-019-0251-8
Wach, S., Brandl, M., Borchardt, H., Weigelt, K., Lukat, S., Nolte, E.,... Aigner, A. (2019). Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. Molecular Therapy - Nucleic Acids, 16, 272-283. https://dx.doi.org/10.1016/j.omtn.2019.02.020
Kahlmeyer, A., Stoehr, C.G., Hartmann, A., Goebell, P., Wullich, B., Wach, S.,... Erlmeier, F. (2019). Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma. Journal of Clinical Medicine, 8(5). https://dx.doi.org/10.3390/jcm8050743
Eckert, A.W., Horter, S., Bethmann, D., Kotrba, J., Kaune, T., Rot, S.,... Kappler, M. (2019). Investigation of the prognostic role of carbonic anhydrase 9 (CAIX) of the cellular mRNA/protein level or soluble CAIX protein in patients with oral squamous cell carcinoma. International Journal of Molecular Sciences, 20(2). https://dx.doi.org/10.3390/ijms20020375
Eckstein, M., Erben, P., Kriegmair, M.C., Worst, T.S., Weiss, C.-A., Wirtz, R.M.,... Erlmeier, F. (2019). Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European journal of cancer, 106, 234-243. https://dx.doi.org/10.1016/j.ejca.2018.11.007
Stoehr, C.G., Steffens, S., Polifka, I., Jung, R., Kahlmeyer, A., Ivanyi, P.,... Taubert, H. (2019). Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients. Scientific Reports, 9. https://dx.doi.org/10.1038/s41598-018-38254-3
Rot, S., Kaune, T., Taubert, H., Greither, T., Kotrba, J., Guettler, A.,... Kappler, M. (2019). Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients. BMC Cancer, 19. https://dx.doi.org/10.1186/s12885-019-5327-8
Tsaur, I., Hüsch, T., Jüngel, E., Schneider, F., Schneider, M., Haferkamp, A.,... Blaheta, R.A. (2019). sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2019.03.001
Taubert, H., Becker, C., Fuessel, S., Seitz, G., Kristiansen, G., Wach, S., & Wullich, B. (2019). The 16th DPKK Annual Conference "Urology meets Pathology". Urologe, 58(6), 686-689. https://dx.doi.org/10.1007/s00120-019-0941-2
Pfannstiel, C., Strissel, P., Chiappinelli, K.B., Sikic, D., Wach, S., Wirtz, R.M.,... Eckstein, M. (2019). The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes. Cancer Immunology Research, 7(6), 923-938. https://dx.doi.org/10.1158/2326-6066.CIR-18-0758

Zuletzt aktualisiert 2017-16-10 um 02:00